[The human cytotoxic T cell response to hepatitis B vaccination]. 1985

T Maeda, and T Saibara, and M Fujikawa, and H Sakaeda, and A Tomita, and M Okino, and S Onishi, and K Ito

UI MeSH Term Description Entries
D008297 Male Males
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D014761 Viral Hepatitis Vaccines Any vaccine raised against any virus or viral derivative that causes hepatitis. Hepatitis, Viral, Vaccines,Hepatitis Vaccines, Viral,Vaccines, Viral Hepatitis

Related Publications

T Maeda, and T Saibara, and M Fujikawa, and H Sakaeda, and A Tomita, and M Okino, and S Onishi, and K Ito
February 1981, Clinical and experimental immunology,
T Maeda, and T Saibara, and M Fujikawa, and H Sakaeda, and A Tomita, and M Okino, and S Onishi, and K Ito
May 1991, The Journal of general virology,
T Maeda, and T Saibara, and M Fujikawa, and H Sakaeda, and A Tomita, and M Okino, and S Onishi, and K Ito
July 1996, Proceedings of the National Academy of Sciences of the United States of America,
T Maeda, and T Saibara, and M Fujikawa, and H Sakaeda, and A Tomita, and M Okino, and S Onishi, and K Ito
May 1990, British journal of industrial medicine,
T Maeda, and T Saibara, and M Fujikawa, and H Sakaeda, and A Tomita, and M Okino, and S Onishi, and K Ito
June 1996, Journal of medical virology,
T Maeda, and T Saibara, and M Fujikawa, and H Sakaeda, and A Tomita, and M Okino, and S Onishi, and K Ito
December 2008, Vaccine,
T Maeda, and T Saibara, and M Fujikawa, and H Sakaeda, and A Tomita, and M Okino, and S Onishi, and K Ito
January 1992, Archives of virology. Supplementum,
T Maeda, and T Saibara, and M Fujikawa, and H Sakaeda, and A Tomita, and M Okino, and S Onishi, and K Ito
July 1996, Blood,
T Maeda, and T Saibara, and M Fujikawa, and H Sakaeda, and A Tomita, and M Okino, and S Onishi, and K Ito
July 1997, Tissue antigens,
T Maeda, and T Saibara, and M Fujikawa, and H Sakaeda, and A Tomita, and M Okino, and S Onishi, and K Ito
July 1992, Gastroenterology,
Copied contents to your clipboard!